By Steven Trader ( June 14, 2016, 8:45 PM EDT) -- The U.S. government on Monday took issue with the reasoning behind a federal judge's decision to deny a whistleblower's request to amend allegations that a Covidien Ltd. unit got Medicare to illegally fund off-label uses for its blood-blocking device, and sought to intervene in the pending First Circuit appeal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.